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a b s t r a c t
Severe acute respiratory syndrome coronavirus (SARS-CoV) envelope (E) protein is a viroporin involved
in virulence. E protein ion channel (IC) activity is speciﬁcally correlated with enhanced pulmonary
damage, edema accumulation and death. IL-1β driven proinﬂammation is associated with those
pathological signatures, however its link to IC activity remains unknown. In this report, we demonstrate
that SARS-CoV E protein forms protein–lipid channels in ERGIC/Golgi membranes that are permeable to
calcium ions, a highly relevant feature never reported before. Calcium ions together with pH modulated
E protein pore charge and selectivity. Interestingly, E protein IC activity boosted the activation of the
NLRP3 inﬂammasome, leading to IL-1β overproduction. Calcium transport through the E protein IC was
the main trigger of this process. These ﬁndings strikingly link SARS-CoV E protein IC induced ionic
disturbances at the cell level to immunopathological consequences and disease worsening in the
infected organism.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Coronaviruses (CoVs) cause respiratory diseases in humans
ranging from common colds to fatal pneumonias (Graham et al.,
2013; Perlman and Netland, 2009). At the end of 2002, the
etiological agent of severe acute respiratory syndrome (SARS-
CoV) emerged in Guandong province, Southeast China, initiating
a global epidemic. Approximately 8000 people were infected by
the virus, whose severe disease resulted in a 10% mortality rate
(Drosten et al., 2003; Rota et al., 2003). The SARS-CoV epidemic
was controlled by the summer of 2003, and the virus has not
naturally reemerged since (http://www.who.int). However, in
2012 a closely related CoV appeared in Saudi Arabia causing the
Middle East respiratory syndrome (MERS-CoV) (Zaki et al., 2012).
MERS-CoV induces acute pneumonia similar to that caused by
SARS-CoV, and is sometimes accompanied with renal failure
(Danielsson and Catchpole, 2012; Zaki et al., 2012). MERS-CoV is
now circulating and spreading throughout the human population,
and to date has infected at least 1356 people leading to death in
484 cases. Initial cases were conﬁned to countries of the Arabian
Peninsula; however, new extensive infection clusters have been
recently reported in other regions such as South Korea (http://
www.who.int). Furthermore, CoVs similar to those causing SARS,
MERS, and many other human and animal diseases have been
detected in bat species circulating all over the globe (Annan et al.,
2013; Chu et al., 2008; Drexler et al., 2010; Falcon et al., 2011;
Muller et al., 2007; Quan et al., 2010). Bats are now considered the
natural host for most CoVs, providing a perfect scenario for
recombination events among different viral species leading to
the emergence of new viruses, able to cross species barriers and
cause devastating illness in other animals and humans (Graham
et al., 2013). For this reason, development and implementation of
broad spectrum treatments and general therapeutic strategies
against CoVs are a high priority.
CoVs are enveloped viruses containing the largest positive-sense
RNA genomes known, around 30 Kb, which encode the viral replicase
and a set of structural proteins: spike (S), envelope (E) and membrane
(M), present in the viral envelope, and nucleocapsid (N) located inside
the viral particle (Enjuanes et al., 2008). The S protein interacts with
the cellular receptor to trigger viral entry into the host cell (Enjuanes
et al., 2008; Wong et al., 2004). The E and M proteins actively
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participate in viral morphogenesis (de Haan et al., 1999; Lim and Liu,
2001; Nguyen and Hogue, 1997; Ruch and Machamer, 2012), and the
N protein coats the viral genome to form a helicoidal nucleocapsid
that remains protected within the viral envelope (Narayanan et al.,
2000). Depending on the CoV species, there are other accessory
proteins, some structural, that are also encoded by the genome. SARS-
CoV encodes the highest number of accessory genes (3a, 6, 7a 7b, 8a,
8b and 9b), which play diverse roles eventually related to pathogen-
esis (Enjuanes et al., 2008).
To analyze the mechanisms leading to the high virulence of
SARS-CoV and MERS-CoV, several mutants affecting their different
genes have been generated (Almazan et al., 2013; DeDiego et al.,
2007; DeDiego et al., 2014a; Scobey et al., 2013; Yount et al., 2005).
Remarkably, deletion of SARS-CoV E gene produced a virus that
was attenuated in at least three different animal models and
conferred protection against SARS-CoV challenge (DeDiego et al.,
2007, 2008, 2011; Fett et al., 2013; Lamirande et al., 2008; Netland
et al., 2010). Small deletions in different domains of the E protein
caused similarly attenuated viruses, and are promising vaccine
candidates (Regla-Nava et al., 2015). In a similar approach, a MERS-
CoV missing the E gene was generated, resulting in a replication-
competent, propagation-defective virus which may also constitute
the basis of a safe attenuated vaccine (Almazan et al., 2013).
The CoV E gene encodes a small transmembrane protein highly
synthesized during infection (Maeda et al., 2001; Nieto-Torres et al.,
2011; Raamsman et al., 2000) that mainly localizes to the Golgi
apparatus and the endoplasmic reticulum Golgi apparatus intermedi-
ate compartment (ERGIC), where it facilitates virus production and
morphogenesis (Cohen et al., 2011; Corse and Machamer, 2002;
Maeda et al., 2001; Nal et al., 2005; Venkatagopalan et al., 2015).
Notably, when the E protein is present, SARS-CoV overstimulates the
NF-κB inﬂammatory pathway (DeDiego et al., 2014b) and, through its
PDZ-binding motif, interacts with the cellular protein syntenin,
triggering p38 MAPK activation (Jimenez-Guardeño et al., 2014).
These signaling cascades result in exacerbated inﬂammation and
immunopathology. The connection between the E protein and
virulence has further encouraged the search for other E protein
functions that may trigger disease worsening.
One of the most striking functions displayed by the CoV E
protein is ion channel (IC) activity. The CoV E protein self
assembles in membranes forming pentameric protein-lipid pores
that allow ion transport (Pervushin et al., 2009; Torres et al., 2007;
Verdia-Baguena et al., 2012; Wilson et al., 2004, 2006). Interest-
ingly, lipid head-groups are integral components of the pore and
regulate ion conductance and selectivity (Verdia-Baguena et al.,
2012, 2013; ). The SARS-CoV E protein showed a mild preference
for cations (Naþ , Kþ) over anions (Cl) when reconstituted in
membranes mimicking the charge and composition of those of the
ERGIC/Golgi. In this scenario, the E protein IC showed no selectiv-
ity for any particular cation (Verdia-Baguena et al., 2012), though
the relevance and consequences of these IC properties in a cellular
context remains unknown.
Alteration of ion, and specially, Ca2þ homeostasis in favor of
infection has been already demonstrated in several viral systems.
To that end a wide range of viruses encode ion conductive proteins
similar to E protein, named viroporins (Nieva et al., 2012). Highly
pathogenic RNA viruses such as human immunodeﬁciency virus-1
(HIV-1), hepatitis C virus (HCV), inﬂuenza A virus (IAV), picorna-
viruses and CoVs, encode one or more of these proteins (Nieva et
al., 2012). Viroporins participate in several steps of the life cycle
and are usually linked with pathogenesis. Whether IC properties
could promote pathways leading to disease worsening has been
unknown for a long time. Recently, it was described that point
mutations that speciﬁcally inhibited SARS-CoV E protein IC activity
caused attenuation (Nieto-Torres et al., 2014). Mice infected with E
protein IC proﬁcient viruses presented extensive disruption of the
pulmonary epithelia and edema accumulation (Nieto-Torres et al.,
2014). Edema is the major determinant of acute respiratory
distress syndrome (ARDS), the pathology induced by SARS-CoV,
leading to death (Graham et al., 2013; Hollenhorst et al., 2011;
Matthay and Zemans, 2011). Edema and an IL-1β mediated
proinﬂammatory response was increased in the lung parenchyma
when E protein IC activity was present (Nieto-Torres et al., 2014).
IL-1β is a potent proinﬂammatory cytokine crucial in resolving
infectious processes; however, its overproduction has been correlated
with diverse severe inﬂammatory diseases such as asthma, ARDS,
gout, atherosclerosis and Parkinson's (Dinarello, 2009; dos Santos
et al., 2012; Martinon et al., 2006; Pugin et al., 1996; Strowig et al.,
2012). Organisms tightly control IL-1β production through macro-
molecular complexes called inﬂammasomes, which are mainly
expressed in macrophages and dendritic cells although other cell
types, such as those of the bronchiolar epithelium, synthesize their
components (Ichinohe et al., 2010; Triantaﬁlou and Triantaﬁlou,
2014). One highly studied inﬂammasome is the nucleotide-binding
oligomerization domain (NOD)-like receptor pyrin domain-containing
protein 3 (NLRP3) inﬂammasome, relevant in the pulmonary tissue.
This complex is composed of the sensing protein NLRP3, the adapter
component apoptosis-associated speck-like protein containing a cas-
pase activation and recruitment domain (ASC) and the catalytically
inactive procaspase-1 (Elliott and Sutterwala, 2015; Latz et al., 2013).
The inﬂammasome components are synthesized under precise dan-
ger stimuli, such as molecular patterns associated to infections.
However, a second signal is sequentially needed to induce their
assembly, which triggers the inﬂammasome. This leads to the
processing of procaspase-1 into active caspase-1, which cleaves
inactive pro-IL-1β into its mature form IL-1β that is released to the
extracellular media to stimulate proinﬂammation (Elliott and
Sutterwala, 2015; Latz et al., 2013). The presence of ionic imbalances
within cells is a main trigger of the NLRP3 inﬂammasome assembly
and activation (Latz et al., 2013). Interestingly, several viroporins
stimulate this pathway through alteration of cell ion homeostasis,
frequently involving Ca2þ imbalances (Ichinohe et al., 2010; Ito et al.,
2012; Triantaﬁlou et al., 2013a; Triantaﬁlou and Triantaﬁlou, 2014).
There is clear evidence correlating NLRP3 inﬂammasomes and
IL-1β driven proinﬂammatory cascades with worsening of several
respiratory diseases, including those caused by viruses (dos Santos
et al., 2012; McAuley et al., 2013; Pugin et al., 1996; Triantaﬁlou
and Triantaﬁlou, 2014). However, the speciﬁc role that viral
proteins with IC activity may play in this process has not been
fully determined. Overproduction of IL-1β in the airways of the
lungs of mice infected with E protein IC proﬁcient SARS-CoVs,
strongly suggested that ion conductivity may be stimulating the
inﬂammasome (Nieto-Torres et al., 2014). Here we demonstrate
that SARS-CoV E protein forms a Ca2þ permeable channel in
ERGIC/Golgi membranes. E protein IC activity alters Ca2þ home-
ostasis within cells boosting the activation of the NLRP3 inﬂam-
masome, which leads to the overproduction of IL-1β. This data
supports that SARS-CoV E protein Ca2þ channel activity may play a
role in disease, through overstimulation of inﬂammasomes leading
to immunopathology. Pharmacological inhibition of this pathway
may constitute the basis for combined therapeutics applicable for
SARS-CoV and other viruses.
Results
The SARS-CoV E protein forms Ca2þ permeable ion channels
Previously, we reported that the SARS-CoV E protein forms
channels that are moderately selective for cations in membranes
mimicking the ERGIC/Golgi (Verdia-Baguena et al., , 2012, 2013).
Within cells, the movement of different cations through the E protein
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pore should be dictated by their respective gradients. Ca2þ possesses
the highest asymmetrical distribution between the ER-Golgi lumen
(hundred μM) and the cytoplasm (around 100 nM) (Zhou et al., 2009),
which should allow the ﬂow of this cation through the E protein IC
channel if it is permeable. To test whether this is the case, E protein ICs
were ﬁrst reconstituted in artiﬁcial neutral lipid membranes in order
to exclude any effect coming from the lipid charge, using 100 mM
CaCl2 solutions. Current jumps corresponding to the assembly of
channels in the lipid membrane were detected (Fig. 1A). The most
frequent current jump, representing the insertion of a single E protein
IC in the lipid membrane, displayed an intensity of 7.272.4 pA.
Interestingly, values multiple of 7.2 pAwere also detected, correspond-
ing to the insertion of two (14.4 pA) or three channels (21.6 pA),
reinforcing the previous observation (Fig. 1A and B). Because lipid
charge can affect channel conductance (Verdia-Baguena et al., 2012,
2013), single channel conductance was analyzed in ERGIC/Golgi-like
membranes that contained approximately 20% negatively charged
lipids. Interestingly, the E protein IC showed a slightly higher unitary
current jump of 1174 pA under these conditions, and multiples of
this value, evidencing the insertion of additional channels, were also
detected (Figs. 1C and D). The presence of the negatively charged lipid
head-groups in the channel pore may facilitate Ca2þ ﬂow through the
Fig. 1. SARS-CoV E protein IC activity in CaCl2 solutions. (A) Current recordings showing intensity jumps (measured in pA) corresponding to the assembly and disassembly of
one or several channels in neutral DPhPC membranes. (B) Histogram representing the intensity of the different current jumps recorded and their respective frequency in
neutral membranes. Conductance (G), which is the ratio between current intensity and the applied voltage, is also indicated (measured in pS). Current jumps (C) and their
corresponding histogram (D) measured in ERGIC/Golgi membranes. (E) Single-channel conductance variation in solutions containing increasing concentrations of CaCl2.
Magenta circles represent data from neutral membranes and blue circles values from ERGIC/Golgi membranes. Error bars show standard deviations from three independent
experiments.
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channel enhancing current intensity under these conditions. This
effect was already reported for E protein and monovalent cations
(Verdia-Baguena et al., 2012).
Additional measurements were performed in aqueous solutions
with decreasing CaCl2 concentrations, to approach Ca2þ amounts
found in the ERGIC/Golgi lumen. IC conductance (G), which is the
ratio between the current intensity and the applied voltage, was
calculated. Single channel conductance scaled almost linearly with
CaCl2 concentration in neutral membranes (Fig. 1E). This reﬂects that
ion conduction inside the E protein IC is similar to the conduction of
the solution, which increases as the electrolyte concentration rises.
These data indicate that the interaction between the channel and the
permeating ions is weak, and are in accordance with E protein
forming a neutral pore in these conditions, as previously reported
for monovalent cation salts (Verdia-Baguena et al., 2013). In ERGIC/
Golgi membranes two different regimes depending on the range of
CaCl2 concentrations were observed. A linear relation between
conductance and CaCl2 concentration was again detected in high
concentrated solutions. However, IC conductance in ERGIC/Golgi
membranes was independent of CaCl2 concentration in low concen-
tration solutions (below 0.2 M), and higher than in neutral mem-
branes (Fig. 1E). This result suggests that E protein acts as a charged
protein–lipid pore in ERGIC/Golgi membranes. In this scenario, the
conductance is regulated by the balance between the ions that ﬂow
into the channel to neutralize the excess of negative charges and the
bulk electrolyte concentration. Collectively, these data indicate that
the E protein forms channels that are highly conductive in CaCl2.
Furthermore, E protein ICs worked very efﬁciently when reconstituted
in ERGIC/Golgi membranes under Ca2þ concentrations approaching
those found in the lumen of the organelles (hundred μM).
To speciﬁcally test E protein selectivity for Ca2þ , i.e. the ability of
the IC to select Ca2þ either by its charge or by its intrinsic properties,
reversal potential (Erev) experiments were performed. The rational of
these experiments is provided next. ICs were reconstituted in lipid
membranes that separated two solutions, one with high and the
other with low CaCl2 concentration. This concentration gradient
induces the movement of ions through the channel to equilibrate
their asymmetric distribution. The potential applied across the
channel, which is required to counteract this ion movement leading
to zero electric current is the Erev. The Erev can be transformed into
channel permeability for Ca2þ (PCa2þ) and Cl (PCl) by using the
Goldman–Hodgkin–Katz equation (Hodgkin and Katz, 1949). To test
whether lipid charge may have an effect on E protein, selectivity
measurements were performed in neutral, ERGIC/Golgi similar
charged membranes, and fully negative-charged membranes. The E
protein IC showed PCa2þ/PCl values of 0.2 (1/5) in neutral mem-
branes. The value of this permeability ratio is barely the same
expected for a non-selective neutral pore just reﬂecting the different
diffusivities of Ca2þ and Cl . Therefore, E protein channel is equally
selective for Cl and Ca2þ in neutral membranes. Interestingly, the
ratio PCa2þ/PCl increased when the E protein IC was assembled in
membranes containing negatively charged lipids, being 0.5 in ERGIC/
Golgi membranes and 1.8 in negative membranes (Fig. 2). These data
indicated that lipid charge largely inﬂuenced the channel preference
for Ca2þ showing that under conditions mimicking the ERGIC/Golgi
environment, E protein displayed a mild selectivity for Ca2þ .
Calcium cations and pH modulate E protein channel selectivity
Multivalent ions, such as Ca2þ , can modulate ion transport
across ICs by interacting with the internal charges of their pores
(Alcaraz et al., 2009; Garcia-Gimenez et al., 2012; Queralt-Martin
et al., 2011). Therefore we tested whether E protein ion selectivity
could be modiﬁed by the presence of a range of small CaCl2
concentrations. Ion selectivity was measured using a ten-fold
concentration gradient of KCl at pH 6 upon symmetrical addition
of very small CaCl2 concentrations (mM range), at both sides of the
membrane. By applying the Erev, the ﬂow of Kþ and Cl ions
Fig. 3. Modulation of SARS-CoV E protein channel selectivity by Ca2þ . (A) Reversal potential (Erev) was measured in asymmetric (500 mM | 50 mM) KCl solutions upon
addition of millimolar CaCl2 concentrations. Two series of experiments were performed: in neutral DPhPC (magenta circles) and negatively charged DPhPS membranes
(green squares). Dotted line shows Erev value corresponding to a non-selective ion channel. (B) Effect of pH on E protein Erev measured under the same KCl conditions above
mentioned in neutral (magenta circles) and negatively charged membranes in the absence (green squares) or the presence of 15 mM CaCl2 (orange squares). Dotted line
shows the Erev value corresponding to a non-selective ion channel. Error bars represent standard deviations from three independent experiments.
Fig. 2. Ca2þ selectivity of SARS-CoV E protein channel. Permeability ratios PCa2þ/
PCl in neutral DPhPC (magenta column), ERGIC/Golgi (blue column) or negatively-
charged DPhPS membranes (green column). Dotted line represents the perme-
ability ratio value for a hypothetical neutral pore. Values above the line represent
cation selectivity, and those below correspond to anion selectivity. Error bars show
standard deviations.
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down their electrochemical potential gradient is prevented. There-
fore, Erev measures the relative preference of the channel for Kþ
cations over Cl anions, but not for Ca2þ , because calcium
concentrations are the same at both sides of the pore. To analyze
the relevance of Ca2þ on IC selectivity, this type of experiments
were performed in neutral and in negatively-charged membranes
(Fig. 3A). In charged membranes the addition of small amounts of
Ca2þ induced signiﬁcant changes in the channel Erev, whereas in
neutral membranes the effect was very small, although still
measurable. These results indicate that Ca2þ interaction with E
protein channel, modifying the effective pore charge, mainly occur
with the lipid charges that line the pore, rather than with acidic
residues of E protein TM domain.
Previously we reported that pH also modulates E protein channel
selectivity by protonation and deprotonation of the titratable residues
present in the pore (Verdia-Baguena et al., 2013). The effect of Ca2þ
and pH on E protein selectivity was simultaneously tested. Erev
titration was studied in the presence or absence of 15 mM CaCl2
under different pH conditions (Fig. 3B). In negatively-charged lipid
membranes, rising pH induced sequential deprotonation of lipid
head-groups and E protein glutamic acid residues as their respective
pKa (1.73 for lipid head-groups and 4.5 for glutamic acid) were
overtaken, conferring an excess of negative charges to the channel
and making it cation selective. The addition of Ca2þ when E protein is
reconstituted in charged membranes reduces the cationic selectivity
or increases the anionic selectivity (i.e., it shifts the reversal potential
towards less negative values), and reversal potential values become
closer to those obtained in neutral membranes. This indicates that
Ca2þ ions interact with the acidic protein residues and the negative
lipid head-groups and decrease the effective negative charge of the E
protein pore. This effect was especially patent at physiological values
of pH (pH 6–7.5). In addition, this interaction of Ca2þ ions with the
protein acidic residues shifts their effective pKa towards lower values.
These results indicate that both Ca2þ and Hþ ions change E channel
transport properties by modifying the charge of the pore, and further
support that Ca2þ enters within E protein IC.
Identiﬁcation of SARS-CoV E protein ion channel mutants lacking
Ca2þ transport
In order to assess the biological impact of SARS-CoV E protein
with and without Ca2þ channel activity, we evaluated previously
constructed mutants containing amino acids substitutions known
to affect the E protein IC. Previously we demonstrated that
mutations N15A and V25F in the transmembrane domain of
SARS-CoV E protein abolished ion conductance in KCl and NaCl
solutions (Verdia-Baguena et al., 2012). New conductance mea-
surements were performed in ERGIC/Golgi membranes in 100 mM
CaCl2 solutions (Fig. 4). Wildtype E protein transmembrane pep-
tides showed conductance values in the range of 110 pS, whereas
no conductance was observed for N15A or V25F mutants, indicat-
ing that these mutations also inhibited Ca2þ transport, and
probably prevent all ion passage as it was previously demon-
strated that they also failed to transport Kþ , Naþ and Cl (Verdia-
Baguena et al., 2012).
Ca2þ transport through SARS-CoV E protein channel activates the
NLRP3 inﬂammasome
Alteration of cellular ion homeostasis by SARS-CoV E protein IC
could have several implications. Previously, we linked E protein IC
with IL-1β triggered proinﬂammation in the lungs of mice, leading
to epithelial cell damage and death (Nieto-Torres et al., 2014).
Higher levels of mature IL-1β were detected in the airways of
infected animals when E protein IC activity was present, suggest-
ing that ion conductance could stimulate the inﬂammasome. To
determine whether this was the case, the inﬂammasome complex
was reconstituted in Vero E6 cells by transient transfection of its
components (NLRP3, ASC and procaspase-1) and the inactive pro-
IL-1β (Lo et al., 2013), in the absence or presence of E protein, with
or without IC activity. All the components of the inﬂammasome,
besides the different versions of E protein were efﬁciently
expressed within cells (Fig. 5A). When pro-IL-1β was transfected
as a control, no signiﬁcant level of active IL-1β was detected in the
supernatant. However, when all the components were supplied to
the cells, the inﬂammasome was stimulated, and active IL-1β was
detected in the media in the range of 600 pg/ml (Fig. 5B). Inter-
estingly, the production of IL-1β was signiﬁcantly enhanced in the
presence of E protein with IC activity (ICþ) (4800 pg/ml). This
stimulation was IC activity dependent, as the E protein mutants
lacking ion conductance (N15A and V25F), represented in the
ﬁgure as EIC1 and EIC

2 , respectively, did not boost IL-1β levels
(Fig. 5B). Stimulation levels found with wildtype E protein were in
the range of those previously reported for other inﬂammasome
activating proteins, using this system (Lo et al., 2013).
Imbalances in Ca2þ within cells have been described as an
inﬂammasome inducer (Ito et al., 2012; Murakami et al., 2012;
Triantaﬁlou et al., 2013b). To test the speciﬁc contribution of SARS-
CoV E protein Ca2þ transport to inﬂammasome activation, the
complex was reconstituted in cells in the presence or absence of E
protein. Cells were subsequently treated with the cell permeant
calcium chelator BAPTA-AM (Fig. 6A). This compound enters cells
and binds Ca2þ preventing inﬂammasome activation (Ito et al.,
2012). Increasing amounts of BAPTA-AM markedly decreased the
levels of secreted IL-1β in the presence of E protein (Fig. 6A, INFL
EICþ), reaching levels close to those obtained when the inﬂam-
masome was assembled alone (Fig. 6A, INFL). The Ca2þ ionophore
ionomycin stimulated active IL-1β accumulation in the cell super-
natant at levels similar to those seen with E protein, further
conﬁrming that Ca2þ imbalances boost IL-1β production
(Fig. 6B). No signiﬁcant differences in cell viability were found
for any of the treatments (Fig. 6C). Collectively, these results
indicate that SARS-CoV E protein activates the NLRP3 inﬂamma-
some through its Ca2þ transport ability.
Discussion
Ion conductive proteins are widely distributed among viruses,
being especially common in RNA viruses (Nieva et al., 2012).
Fig. 4. Mutations inhibiting SARS-CoV E protein conductance in CaCl2. Single
channel conductance was measured in 100 mM CaCl2, in the absence of any
peptide (C , gray column), or in the presence of wildtype SARS-CoV E protein
transmembrane domain peptide (WT, black column), or the mutant peptides N15A
(red column) and V25F (blue column). Error bars represent standard deviations.
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Conductance of ions facilitate diverse processes of the viral life cycle
such as entry, takeover of organelles to serve as platforms for viral
replication, protection of viral proteins from acidic cell compartments,
and trafﬁcking of nascent virions (Nieva et al., 2012). In addition,
viroporins are often linked to pathogenesis, and in general, mutant
viruses lacking them are attenuated, in many cases serving as effective
Fig. 5. Inﬂammasome activation through SARS-CoV E protein ion channel activity. The components of the NLRP3 inﬂammasome (INFL), NLRP3 (NLRP3-HA), ASC (ASC-
mCherry), procaspase-1 (procaspase-1-Myc) and pro-IL-1β were transfected in Vero E6 cells, in the absence or presence of SARS-CoV E protein with (ICþ) or without (IC)
ion channel activity. EIC1 represents the N15A mutant and EIC

2 indicates the V25F mutant. As a negative control, cells were transfected solely with pro-IL-1β (C).
(A) Western blot showing the presence of the inﬂammasome complex components and E protein within Vero E6 cells lysates. β-Actin was also detected as a loading control.
(B) Levels of active IL-1β present in the cell supernatant. Error bars represent standard deviations from three independent experiments. Statistically signiﬁcant data are
indicated with two asterisks (Student's t-test p valueo0.01).
Fig. 6. Inﬂammasome activation through SARS-CoV E protein Ca2þ channel activity. (A) The inﬂammasome complex (INFL) was reconstituted in cells without or with
wildtype E protein (EICþ) in the presence of increasing concentrations (μM) of the cell permeable Ca2þ chelator BAPTA-AM. DMSO was added as negative control (). The
levels of active IL-1β present in the cell media were measured by ELISA. (B) Activation of the inﬂammasome by the Ca2þ ionophore ionomycin. Error bars represent standard
deviations from three independent experiments; statistically signiﬁcant data are indicated with two asterisks (Student's t-test p valueo0.01). (C) Cell viability MTT assay.
Optical densities (OD) representing cellular metabolic activity under the different experimental conditions were measured at 570 nm.
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vaccines (DeDiego et al., 2007; Netland et al., 2010; Watanabe et al.,
2009; Whitehead et al., 1999). Viroporin removal is frequently
accompanied by a defect in viral production, which by itself can
explain virulence attenuation. However, recent studies have indicated
that IC activity may speciﬁcally trigger pathways leading to pathology.
Previously we demonstrated that SARS-CoVs proﬁcient in E protein IC
activity caused increased damage of the pulmonary epithelia and
edema accumulation (Nieto-Torres et al., 2014). These disease symp-
toms correlated with an immunopathological response mediated by
proinﬂammatory cytokines such as IL-6, TNF and IL-1β, the latter
being a crucial mediator of this cascade. IL-1β overproduction is
linked to a wide range of inﬂammatory pathologies including those
caused by respiratory viruses (dos Santos et al., 2012; McAuley et al.,
2013; Pugin et al., 1996; Triantaﬁlou and Triantaﬁlou, 2014). Here, we
report for the ﬁrst time that CoV E protein formed an IC that
transported Ca2þ in ERGIC/Golgi membranes, where this protein
locates, which may have important consequences on cell physiology.
In fact, Ca2þ leakage through E protein IC induced the activation of
the NLRP3 inﬂammasome resulting in overproduction of IL-1β. This
ﬁnding together with previous in vivo observations indicates that IC
activity correlates with proinﬂammation and pathology.
Generally, viroporins form poorly selective ion channels (Nieva
et al., 2012). Therefore, the subcellular location where viroporins
assemble and the conditions of that particular environment are
crucial determinants of their impact on cellular ionic homeostasis.
Previously, we reported that SARS-CoV E protein showed mild
selectivity for cations (Naþ and Kþ) when reconstituted in ERGIC/
Golgi membranes, mostly conferred by the negative charges of the
lipids (Verdia-Baguena et al., 2012, 2013). High concentration
gradients are found for Naþ and Kþ between the cell interior
and the extracellular media (Dubyak, 2004). However, there is no
known asymmetric distribution for either of these ion species
between the lumen of ERGIC/Golgi and the cell cytoplasm
(Chandra et al., 1991; Schapiro and Grinstein, 2000). Accordingly,
minimal net transport of Naþ and Kþ through E protein pore
should be expected, and therefore the biological relevance of these
processes may be also limited. In contrast, the ER and Golgi
apparatus store high amounts of calcium ions by the action of
pumps such as the sarcoendoplasmic reticulum Ca2þ ATPase
(SERCA) and the secretory pathway Ca2þ ATPase (SPCA)
(Wuytack et al., 2002). This creates an enormous gradient of
around 1000-fold between the lumen of these organelles and
the cytoplasm (Zhou et al., 2009). The gradient allows controlled
eventual and temporal leakages of Ca2þ into the cytoplasm that
trigger several processes relevant to cell physiology. Interestingly,
we have shown above that SARS-CoV E protein IC was also
permeable to Ca2þ in ERGIC/Golgi membranes. Furthermore,
Ca2þ interacted with the negative charges of the protein-lipid
pore, modulating its properties. Several other viroporins are
known to transport Ca2þ , resulting in leakage of this cation from
its intracellular stores. Rotavirus NSP4 protein as well as Coxsack-
ievirus, encephalomyocarditis virus, and poliovirus 2B proteins
deplete ER and/or Golgi Ca2þ concentrations in favor of viral
proliferation (Campanella et al., 2004; Crawford et al., 2012; de
Jong et al., 2008). Alteration of protein trafﬁcking, manipulation of
apoptosis, and control of autophagy are some of the processes
controlled by these Ca2þ efﬂuxes. Whether some of these aspects
are inﬂuenced in a similar manner during SARS-CoV infection will
be explored in future experiments.
Protons (Hþ) are also actively conﬁned to the lumen of the Golgi
apparatus and those of the organelles of the secretory pathway in a
process that acidiﬁes their interior and creates a gradient with the
cytoplasm (Paroutis et al., 2004). Considering that the E protein IC
weakly interacts with circulating ions and that pH can modulate its
net charge, it is highly likely that protons will also ﬂow through the IC
within cells. This is not an isolated case, as several viroporins such as
HCV p7 and IAV M2 are known to transport protons, and others such
as the 2B protein of the picornaviridae family transport both Hþ and
Ca2þ (de Jong et al., 2006; Wang et al., 1994; Wozniak et al., 2010).
Alkalinization of the Golgi lumen is crucial to protect acid-sensitive
viral progeny and prevent premature activation of viral proteins
involved in entry processes (Sakaguchi et al., 1996; Wozniak et al.,
2010). SARS-CoV E protein IC mutants did not show profound growth
defects, although they were outgrown in competition assays by IC
proﬁcient viruses, which suggests better proliferation when E protein
ion conductance was present (Nieto-Torres et al., 2014). Whether
alkalization of intracellular compartments by E protein IC may assist in
SARS-CoV production remains to be explored. Besides these consid-
erations, it cannot be excluded that IC activity may have a greater
impact in SARS-CoV production. Inhibition of E protein IC activity may
be compensated by the action of two other viroporins encoded by
SARS-CoV, the 3a and 8a (Chen et al., 2011; Lu et al., 2006); further
experiments are being performed to answer this question.
Disruption of ion homeostasis can have profound deleterious
effects for the cells; consequently, they have evolved mechanisms to
sense and control these disturbances. Ion imbalances associated with
infecting pathogens are recognized by inﬂammasomes, which are
components of the innate immune system. Inﬂammasomes orches-
trate proinﬂammatory responses to ﬁght viral infections, IL-1β being
one of the major players (Strowig et al., 2012). However, increasing
evidence indicates that overstimulation of this pathway can lead to
undesirable effects for the organism. In fact, immunopathology rather
than direct viral destruction of infected cells is the main cause of
severe disease in many viral illnesses (McAuley et al., 2013; Meduri
et al., 1995; Triantaﬁlou and Triantaﬁlou, 2014). SARS-CoVs that lack E
protein IC activity induced less proinﬂammation and active IL-1β,
suggesting that IC activity could be a trigger of this pathway (Nieto-
Torres et al., 2014). Indeed, wildtype E protein but not its IC mutants
boosted the production of mature IL-1β through the mediation of a
reconstituted inﬂammasome. Ca2þ was the main trigger of this
process, as chelation of this ion abolished enhanced IL-1β production,
and a Ca2þ ionophore produced a similar simulation. E proteins from
other human respiratory CoVs, such as MERS-CoV and HCoV-229E,
also display ion channel properties (Surya et al., 2015; Verdia-
Baguena et al., 2012; Wilson et al., 2006). Investigating whether these
proteins may favor Ca2þ transport and activation of the inﬂamma-
some represents a relevant issue. Furthermore, the identiﬁcation of a
possible correlation between the extent of inﬂammasome activation
and the disease symptoms caused by these viruses, highly deleterious
in the case of SARS-CoV andMERS-CoV, andmild in the case of HCoV-
229E, could provide key information on the impact of this pathway on
the pathological outcome induced by different CoVs, and will be
analyzed in future experiments.
This study provides new insights into the molecular mechan-
isms governing CoV viroporin activity and the consequences of
this function in viral pathogenesis. What is more, IL-1β over-
production has been related with the pathology induced by SARS-
CoV and other respiratory viruses (Triantaﬁlou and Triantaﬁlou,
2014). Our results suggest that development of speciﬁc IC inhibi-
tors and implementation of novel compounds decreasing inﬂam-
masome driven immunopathology (Coll et al., 2015) may be a
valuable complement to other antiviral approaches for the treat-
ment of these infectious diseases.
Materials and methods
Cells
The African green monkey kidney-derived Vero E6 cells were
kindly provided by Eric Snijder (Medical Center, University of
Leiden, The Netherlands). Cells were grown at 37 1C with an
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atmosphere of 98% humidity and 5% CO2, in Dulbecco's modiﬁed
Eagle medium (DMEM, GIBCO) supplemented with 25 mM HEPES,
2 mM L-glutamine (SIGMA), 1% non-essential amino acids (SIGMA)
and 10% fetal bovine serum (FBS, BioWhittaker).
Peptide synthesis and ion channel measurements in artiﬁcial lipid
membranes
Synthetic peptides representing the full-length SARS-CoV E
protein, or its transmembrane domain (amino acids 7–38) con-
taining point mutations that inhibited ion channel activity (N15A
and V25F), were generated by standard phase synthesis and
puriﬁed by HPLC, as previously described (Verdia-Baguena et al.,
2012). Ion channels were reconstituted in lipid membranes com-
posed of diphytanoyl phosphatidylcholine (DPhPC), diphytanoyl
phosphatidylserine (DPhPS), or a mixture of 59% dioleoyl phos-
phatidylcholine (DOPC), 24% dioleoyl phosphatidylethanolamine
(DOPE), and 17% dioleoyl phosphatidylserine (DOPS) (Avanti polar
lipids, Inc., Alabaster, AL). The membranes separated two cham-
bers ﬁlled with electrolytic solutions of CaCl2 or KCl. Ion channel
insertion was achieved by adding 0.5–1 μl of a 300 μg/ml solution
of synthetic protein or peptides in a acetonitrile:isopropanol
(40:60) buffer to one of the chambers (cis). All measurements
were performed at room temperature (2371 1C).
The single-channel conductance was obtained from current
measurements under an applied potential of þ100 mV in symme-
trical salt solutions of 1 M CaCl2 buffered with 5 mM HEPES at pH
6. The conductance values were evaluated using the Gaussian ﬁt
tool of Sigma Plot 10.0 (Systat Software, Inc).
For the selectivity measurements the reversal potential (Erev) was
obtained under a ten-fold salt concentration gradient (500 mM /
50 mM). One or several channels were inserted into the bilayer
causing a net ionic current due to the concentration gradient. Then
the ionic current was manually set to zero by adjusting the applied
potential. The potential needed to achieve zero current represents the
Erev; conversion of Erev into the channel permeability (Pþ/P) was
by done using the Goldman–Hodgkin–Katz (GHK) equation (Hodgkin
and Katz, 1949). The effect of Ca2þ on E protein ion selectivity
was deﬁned by measuring Erev in a ten-fold KCl concentration
gradient (500 mM/50mM) buffered with 5 mM HEPES at pH 6, in
the presence of increasing concentrations of CaCl2. The functional
interaction of Ca2þ with E protein–lipid pore was evaluated measur-
ing Erev in DPhPC and DPhPS membranes under different pH values,
with or without 15 mM CaCl2.
Inﬂammasome reconstitution in Vero E6 cells
Sub-conﬂuent monolayers of Vero E6 cells seeded onto 24-well
plates were transfected using Lipofectamine 2000 (Invitrogen) and
a set of plasmids encoding the components of the NLRP3 inﬂam-
masome (Lo et al., 2013; Wu et al., 2014): 200 ng of pcDNA4-proIL-
1β, 25 ng of pcDNA4-NLRP3-HA, 20 ng pcDNA4-ASC-mCherry, and
10 ng of pcDNA4-procaspase-1-Myc, with 100 ng of empty
pcDNA3, as a control, or 100 ng of either pcDNA3-E, pcDNA3-
EN15A or pcDNA3-EV25F. Cell lysates and culture supernatants
were collected 24 h after transfection. The secreted active IL-1β
was measured by ELISA according to the manufacturer's speciﬁca-
tions (eBioscience).
Cell protein extract preparation and western blot assays
Cells were lysed in a buffer containing Tris/HCl 10 mM, EDTA
1 mM, NaCl 150 mM, IGEPAL 1%, and complete protease inhibitor
(Roche) at pH 8. Inﬂammasome proteins were detected by western
blot using a mouse anti-HA antibody (Sigma) to detect NRLP3-HA,
mouse anti-mCherry (Abcam) to bind ASC-mCherry, rabbit anti-
Myc (Abcam) to label procaspase-1-Myc, and rabbit anti-human
IL-1β (Cell signaling). SARS-CoV E protein was detected using a
polyclonal antiserum produced in rabbits (Nieto-Torres et al.,
2011). As a loading control, beta-actin was labeled using a mouse
monoclonal antibody (Abcam). Bound antibodies were detected
using HRP-conjugated goat anti-rabbit IgG and rabbit anti-mouse
IgG and the Immobilon Western chemiluminicesce substrate
(Millipore), following manufacturer's speciﬁcations.
Effect of BAPTA-AM and ionomycin treatments on inﬂammasome
activation
Fresh supplemented DMEM containing the indicated concen-
tration of the cell permeant calcium chelator BAPTA-AM (Life
technologies) was added to cells 4 h after transfection of the
inﬂammasome components and incubated 30 min at 37 1C. Then,
media was removed and a second treatment with fresh media
containing BAPTA-AM was performed. Supernatants were col-
lected 20 h post-BAPTA-AM treatment. Ionomycin (Life technolo-
gies) was added at 1 μM 4 h after transfection and incubated for
20 h.
Cell viability assay
The MTT colorimetric method was used to measure cell meta-
bolic activity. Cell media of transfected cells was replaced by fresh
DMEM supplemented with 10% FCS and 500 μg/ml of MTT. Cells
were incubated 2 h at 37 1C. After that, media was removed and a
solution containing 0.04 M HCl 0.1% Nonidet P-40 in isopropanol
was added. Plates were gently mixed to obtain a homogeneous
solution, and optic density was measured at 570 nm.
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